{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:28:04Z","timestamp":1767374884031,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jns.2021.117410","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T16:25:03Z","timestamp":1616257503000},"page":"117410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Adherence to anticoagulant guideline for atrial fibrillation: A large care gap among stroke patients in a rural population"],"prefix":"10.1016","volume":"424","author":[{"given":"Johan","family":"Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Koza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durgesh","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Shahjouei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Mobasshir Arshed","family":"Naved","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Taimur","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Adibuzzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vida","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Zand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jns.2021.117410_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the american heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jns.2021.117410_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"9989","key":"10.1016\/j.jns.2021.117410_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jns.2021.117410_bb0020","doi-asserted-by":"crossref","first-page":"e0168010","DOI":"10.1371\/journal.pone.0168010","article-title":"Stroke as the first manifestation of atrial fibrillation","volume":"11","author":"Jaakkola","year":"2016","journal-title":"PLOS ONE"},{"issue":"23","key":"10.1016\/j.jns.2021.117410_bb0025","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the Management of Patients with Atrial Fibrillation","volume":"130","author":"January","year":"2014","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.jns.2021.117410_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjmed.2010.05.007","article-title":"Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation","volume":"124","author":"Lip","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2021.117410_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2015.09.006","article-title":"Paroxysmal atrial fibrillation and the hazards of under-treatment","volume":"202","author":"Aronis","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.jns.2021.117410_bb0040","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/STROKEAHA.116.016146","article-title":"Secondary versus primary stroke prevention in atrial fibrillation: insights from the Darlington atrial fibrillation registry","volume":"48","author":"Mazurek","year":"2017","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.jns.2021.117410_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med."},{"issue":"7","key":"10.1016\/j.jns.2021.117410_bb0050","doi-asserted-by":"crossref","first-page":"e67806","DOI":"10.1371\/journal.pone.0067806","article-title":"Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice","volume":"8","author":"Arts","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jns.2021.117410_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12959-018-0177-1","article-title":"Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study","volume":"16","author":"Gebreyohannes","year":"2018","journal-title":"Thromb. J."},{"issue":"9","key":"10.1016\/j.jns.2021.117410_bb0060","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2021.117410_bb0065","first-page":"1","article-title":"Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA","volume":"19","author":"Deitelzweig","year":"2020","journal-title":"J Med Econ."},{"issue":"7","key":"10.1016\/j.jns.2021.117410_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/clc.22133","article-title":"Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with Nonvalvular atrial fibrillation: a Danish survey: antithrombotic treatment in AF","volume":"36","author":"Brandes","year":"2013","journal-title":"Clin. Cardiol."},{"issue":"5","key":"10.1016\/j.jns.2021.117410_bb0075","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jns.2021.117410_bb0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.STR.31.6.1217","article-title":"Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission","volume":"31","author":"Cohen","year":"2000","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.jns.2021.117410_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11319540-000000000-00000","article-title":"Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study","volume":"27","author":"Tulner","year":"2010","journal-title":"Drugs Aging."},{"issue":"1","key":"10.1016\/j.jns.2021.117410_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12872-020-01330-6","article-title":"Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.jns.2021.117410_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420971895","article-title":"Sex disparity in long-term stroke recurrence and mortality in a rural population in the United States","volume":"13","author":"Lambert","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"9","key":"10.1016\/j.jns.2021.117410_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2158","article-title":"Trends and variation in Oral anticoagulant choice in patients with atrial fibrillation, 2010\u20132017","volume":"38","author":"Zhu","year":"2018","journal-title":"Pharmacother J Hum Pharmacol Drug Ther."},{"issue":"4","key":"10.1016\/j.jns.2021.117410_bb0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/europace\/euv242","article-title":"Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings","volume":"18","author":"Mikkelsen","year":"2016","journal-title":"Europace."},{"issue":"7","key":"10.1016\/j.jns.2021.117410_bb0110","doi-asserted-by":"crossref","first-page":"e1003146","DOI":"10.1371\/journal.pmed.1003146","article-title":"Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): A prospective multicenter study","volume":"17","author":"Chen","year":"2020","journal-title":"PLOS Med"},{"issue":"7","key":"10.1016\/j.jns.2021.117410_bb0115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the CHA 2 DS 2 -VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation","volume":"126","author":"Lane","year":"2012","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jns.2021.117410_bb0120","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.jns.2021.117410_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12911-020-01154-6","article-title":"A predictive analytics model for differentiating between transient ischemic attacks (TIA) and its mimics","volume":"20","author":"Stanciu","year":"2020","journal-title":"BMC Med Inform Decis Mak."},{"key":"10.1016\/j.jns.2021.117410_bb0130","doi-asserted-by":"crossref","first-page":"100193","DOI":"10.1016\/j.ensci.2019.100193","article-title":"Rate and associated factors of transient ischemic attack misdiagnosis","volume":"15","author":"Sadighi","year":"2019","journal-title":"eNeurologicalSci."},{"key":"10.1016\/j.jns.2021.117410_bb0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fneur.2019.00294","article-title":"Six-month outcome of transient ischemic attack and its mimics","volume":"10","author":"Sadighi","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.117410_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-9560-6-6","article-title":"Examining warfarin underutilization rates in patients with atrial fibrillation: detailed chart review essential to capture contraindications to warfarin therapy","volume":"6","author":"Srivastava","year":"2008","journal-title":"Thromb. J."},{"issue":"11","key":"10.1016\/j.jns.2021.117410_bb0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1497.2001.10432.x","article-title":"Is warfarin really underused in patients with atrial fibrillation?","volume":"16","author":"Weisbord","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.jns.2021.117410_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.jns.2021.117410_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/ene.12820","article-title":"Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke study","volume":"23","author":"Palom\u00e4ki","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.117410_bb0160","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.amjcard.2018.01.038","article-title":"Usefulness of the CHA(2)DS(2)-VASc and HAS-BLED scores in predicting the risk of stroke versus intracranial bleeding in patients with atrial fibrillation (from the FibStroke study)","volume":"121","author":"Jaakkola","year":"2018","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.jns.2021.117410_bb0165","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1060028020933186","article-title":"Validation of bleeding risk prediction scores for patients with major bleeding on direct Oral anticoagulants","volume":"54","author":"Tchen","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jns.2021.117410_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/VHRM.S187656","article-title":"When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics","volume":"15","author":"Seelig","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"issue":"12","key":"10.1016\/j.jns.2021.117410_bb0175","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.5603\/KP.a2013.0179","article-title":"Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland","volume":"71","author":"Bednarski","year":"2013","journal-title":"Kardiol. Pol."},{"issue":"6","key":"10.1016\/j.jns.2021.117410_bb0180","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.006","article-title":"Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial Cardioembolic stroke who had Nonvalvular atrial fibrillation","volume":"22","author":"Deguchi","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.jns.2021.117410_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1076029613491459","article-title":"Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry","volume":"21","author":"Kaya","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"03","key":"10.1016\/j.jns.2021.117410_bb0190","first-page":"465","article-title":"Evaluation of patients\u2019 attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"LaHaye","year":"2014","journal-title":"Thromb. Haemost."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:54:05Z","timestamp":1758383645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"alternative-id":["S0022510X21001039"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117410","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to anticoagulant guideline for atrial fibrillation: A large care gap among stroke patients in a rural population","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117410"}}